• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公平的受试者选择的四个方面。

Four Faces of Fair Subject Selection.

机构信息

University of North Carolina at Chapel Hill.

出版信息

Am J Bioeth. 2020 Feb;20(2):5-19. doi: 10.1080/15265161.2019.1701731.

DOI:10.1080/15265161.2019.1701731
PMID:31990253
Abstract

Although the principle of fair subject selection is a widely recognized requirement of ethical clinical research, it often yields conflicting imperatives, thus raising major ethical dilemmas regarding participant selection. In this paper, we diagnose the source of this problem, arguing that the principle of fair subject selection is best understood as a bundle of four distinct sub-principles, each with normative force and each yielding distinct imperatives: (1) fair inclusion; (2) fair burden sharing; (3) fair opportunity; and (4) fair distribution of third-party risks. We first map out these distinct sub-principles, and then identify the ways in which they yield conflicting imperatives for the design of inclusion and exclusion criteria, and the recruitment of participants. We then offer guidance for how decision makers should navigate these conflicting imperatives to ensure that participants are selected fairly.

摘要

虽然公平的受试者选择原则是伦理临床研究的一个广泛认可的要求,但它往往会产生相互冲突的命令,从而对参与者的选择产生重大的伦理困境。在本文中,我们诊断了这个问题的根源,认为公平的受试者选择原则最好被理解为一组四个不同的子原则,每个子原则都有规范的力量,每个子原则都产生不同的命令:(1)公平包容;(2)公平负担分担;(3)公平机会;(4)第三方风险的公平分配。我们首先阐述了这些不同的子原则,然后确定了它们在制定纳入和排除标准以及招募参与者方面产生相互冲突的命令的方式。然后,我们为决策者提供了如何驾驭这些相互冲突的命令的指导,以确保公平地选择参与者。

相似文献

1
Four Faces of Fair Subject Selection.公平的受试者选择的四个方面。
Am J Bioeth. 2020 Feb;20(2):5-19. doi: 10.1080/15265161.2019.1701731.
2
How the CIOMS guidelines contribute to fair inclusion of pregnant women in research.《CIOMS 指南如何促进公平纳入孕妇参与研究》。
Bioethics. 2019 Mar;33(3):367-373. doi: 10.1111/bioe.12520. Epub 2018 Oct 20.
3
The history and moral foundations of human-subject research.人体研究的历史与道德基础。
Am J Phys Med Rehabil. 2007 Feb;86(2):82-5. doi: 10.1097/PHM.0b013e31802f00cd.
4
Standing by our principles: meaningful guidance, moral foundations, and multi-principle methodology in medical scarcity.坚守我们的原则:医疗资源稀缺情况下的有意义指导、道德基础和多原则方法。
Am J Bioeth. 2010 Apr;10(4):46-8. doi: 10.1080/15265161003650528.
5
To Enroll or Not to Enroll?: A Researcher Struggles with the Decision to Involve Study Participants in a Clinical Trial That Could Save Their Lives.是否招募?:一位研究人员在决定让研究参与者参与一项可能挽救他们生命的临床试验时陷入挣扎。
Narrat Inq Bioeth. 2017;7(1):71-77. doi: 10.1353/nib.2017.0019.
6
Fair inclusion of men and women in Australian clinical research: views from ethics committee chairs.澳大利亚临床研究中男性和女性的公平纳入:伦理委员会主席的观点
Med J Aust. 2008 Jun 2;188(11):653-6. doi: 10.5694/j.1326-5377.2008.tb01824.x.
7
Fair subject selection in clinical research: formal equality of opportunity.临床研究中的公平受试者选择:机会的形式平等
J Med Ethics. 2016 Oct;42(10):672-7. doi: 10.1136/medethics-2015-103311. Epub 2016 Jul 18.
8
When clinical trials compete: prioritising study recruitment.当临床试验竞争时:优先考虑研究招募。
J Med Ethics. 2017 Dec;43(12):803-809. doi: 10.1136/medethics-2016-103680. Epub 2017 Jan 20.
9
The ethical justification for inclusion of neonates in pragmatic randomized clinical trials for emergency newborn care.将新生儿纳入紧急新生儿护理实用随机临床试验的伦理理由。
BMC Pediatr. 2019 Jul 2;19(1):218. doi: 10.1186/s12887-019-1600-x.
10
Complete lives, incomplete theories.完整的人生,不完整的理论。
Am J Bioeth. 2010 Apr;10(4):58-60. doi: 10.1080/15265161003632997.

引用本文的文献

1
Scientists' and Policy Professionals' Views on the Translational Pipeline of Human Gene Editing.科学家和政策专业人士对人类基因编辑转化流程的看法。
Am J Bioeth. 2025 Jun;25(6):28-30. doi: 10.1080/15265161.2025.2497979. Epub 2025 Jun 6.
2
Adaptive Recruitment Resource Allocation to Improve Cohort Representativeness in Participatory Biomedical Datasets.自适应招募资源分配以提高参与式生物医学数据集中队列的代表性
AMIA Annu Symp Proc. 2025 May 22;2024:192-201. eCollection 2024.
3
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groups.
分散式临床试验中的多样性:优先纳入代表性不足的群体。
BMC Med Ethics. 2025 Apr 24;26(1):51. doi: 10.1186/s12910-025-01211-7.
4
The Importance of Including Underserved Populations in Research.在研究中纳入服务不足人群的重要性。
Pharmaceut Med. 2025 Mar;39(2):59-71. doi: 10.1007/s40290-025-00562-1. Epub 2025 Apr 1.
5
Ethno-racial categorisations for biomedical studies: the fair selection of research participants and population stratification.生物医学研究中的种族分类:研究参与者的公平选择与群体分层
Synthese. 2024;204(4):130. doi: 10.1007/s11229-024-04769-8. Epub 2024 Oct 2.
6
The Ethics of Human Embryo Editing via CRISPR-Cas9 Technology: A Systematic Review of Ethical Arguments, Reasons, and Concerns.通过CRISPR-Cas9技术进行人类胚胎编辑的伦理问题:伦理观点、理由及担忧的系统综述
HEC Forum. 2025 Jun;37(2):267-303. doi: 10.1007/s10730-024-09538-1. Epub 2024 Sep 20.
7
A comparative ethical analysis of the Egyptian clinical research law.埃及临床研究法的比较伦理分析。
BMC Med Ethics. 2024 Apr 30;25(1):48. doi: 10.1186/s12910-024-01040-0.
8
A Representativeness-informed Model for Research Record Selection from Electronic Medical Record Systems.从电子病历系统中选择研究记录的代表性信息模型。
AMIA Annu Symp Proc. 2023 Apr 29;2022:259-268. eCollection 2022.
9
Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials.提高 I 期健康志愿者试验中人类受试者保护的伦理标准。
Ethics Hum Res. 2022 Sep;44(5):2-21. doi: 10.1002/eahr.500139.
10
Reviewing fair subject selection considerations for the unique case of post sequelae COVID-19 translational studies.审视针对新冠后遗症转化研究这一独特案例的公平受试者选择考量因素。
J Clin Transl Sci. 2022 Jul 7;6(1):e91. doi: 10.1017/cts.2022.425. eCollection 2022.